8 episodes

The AmerisourceBergen Insights podcast is your source for actionable perspective on the issues that matter most to healthcare providers and pharmaceutical manufacturers. We'll cover topics ranging from commercialization, distribution, and utilization of medications to health policy and the social issues impacting healthcare today. Listen in, and visit amerisourcebergen.com/insights for more.

AmerisourceBergen Insights AmerisourceBergen

    • Health & Fitness
    • 5.0 • 6 Ratings

The AmerisourceBergen Insights podcast is your source for actionable perspective on the issues that matter most to healthcare providers and pharmaceutical manufacturers. We'll cover topics ranging from commercialization, distribution, and utilization of medications to health policy and the social issues impacting healthcare today. Listen in, and visit amerisourcebergen.com/insights for more.

    • video
    Milestones for biosimilars in 2002 and looking ahead to 2023

    Milestones for biosimilars in 2002 and looking ahead to 2023

    Listen as AmerisourceBergen experts discuss the continuing evolution of the biosimilar marketplace and share how we are inspiring confidence and uptake among key stakeholders.

    • 9 min
    Live from Advanced Therapies Week with TrakCel

    Live from Advanced Therapies Week with TrakCel

    The booming pipeline of cell and gene therapies, and their unique requirements, means both hope for patients and potential around eligibility and coverage barriers. We talk to experts from AmerisourceBergen and TrakCel about a new partnership for these innovative treatments that can improve speed to therapy, streamline the path to care, and create a heightened level of connectivity across the supply chain.

    • 25 min
    More on PSAOs: Investing in independents

    More on PSAOs: Investing in independents

    We're joined again by AmerisourceBergen's Peter Kounelis to discuss how the right PSAO should invest in and advocate for independent pharmacies. 

    • 8 min
    The evolution of the PSAO

    The evolution of the PSAO

    With independent pharmacy facing increasing pressures from the tight reimbursement landscape, how can the right contracting strategy help? Peter Kounelis, Vice President of Elevate Provider Network at AmerisourceBergen, joins us to discuss the evolution of the PSAO. Visit wearegnp.com to learn more about Elevate.

    • 14 min
    Insulin biosimilars part 2

    Insulin biosimilars part 2

    We’re discussing insulin biosimilars with Sean McGowan and Michelle Jesse from AmerisourceBergen’s biosimilars team, along with Brad Tallamy, Senior Director of Government Affairs at AmerisourceBergen. In part two of a two-part series on insulin biosimilars, we’ll talk about how pharmacies can prepare to dispense biosimilars once these products receive interchangeability status.

    • 15 min
    Insulin biosimilars part 1

    Insulin biosimilars part 1

    We’re revisiting the biosimilars market with Sean McGowan and Michelle Jesse from AmerisourceBergen’s biosimilars team, along with Brad Tallamy, Senior Director of Government Affairs at AmerisourceBergen. In part one of a two-part series on insulin biosimilars, we’ll talk about what these new drugs could mean for the category.

    • 13 min

Customer Reviews

5.0 out of 5
6 Ratings

6 Ratings

Top Podcasts In Health & Fitness

Scicomm Media
Jay Shetty
Aubrey Gordon & Michael Hobbes
Peter Attia, MD
Slumber Studios
Lewis Howes